Atb Cap Markets Increases Earnings Estimates for Cresco Labs

Cresco Labs Inc. (OTCMKTS:CRLBF) – Research analysts at Atb Cap Markets lifted their FY2025 earnings per share (EPS) estimates for Cresco Labs in a report issued on Monday, December 9th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings per share of ($0.07) for the year, up from their previous forecast of ($0.09). Atb Cap Markets currently has a “Hold” rating on the stock. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share.

Other equities analysts also recently issued research reports about the stock. Roth Capital upgraded shares of Cresco Labs to a “strong-buy” rating in a research report on Sunday, November 10th. Cormark downgraded Cresco Labs from a “moderate buy” rating to a “hold” rating in a research note on Monday, November 11th. Four analysts have rated the stock with a hold rating, two have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $2.50.

Cresco Labs Stock Down 3.8 %

CRLBF opened at $1.00 on Wednesday. The stock has a market capitalization of $488.14 million, a P/E ratio of -5.00 and a beta of 1.73. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.39 and a current ratio of 1.97. Cresco Labs has a one year low of $1.00 and a one year high of $2.65. The business’s 50-day simple moving average is $1.38 and its 200-day simple moving average is $1.57.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.